Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Halo Labs Completes $6M Series C Growth Financing
Halo Labs, a leading life science instrumentation company announced it has raised $6M in series C financing. […]
Biosyntia Closes a 11.5 Million EUR Round to Launch World’s First Bio-based Vitamin B7
Biosyntia has secured a Series B funding round of 11.5 million euros from a strong […]
Thabor Therapeutics Secures €2 Million in Deep Tech Financing From Bpifrance
Thabor Therapeutics, a company developing an innovative treatment for patients living with chronic mucosal inflammatory […]
Faeth Therapeutics Raises $47 Million to Advance Clinical Trials and Feed the Fight Against Cancer
Faeth Therapeutics, a cancer metabolism company, today announced the closing of a $47 million Series A round […]
VistaPath Raises $4M to Modernize Pathology Labs Using Computer Vision and Artificial Intelligence
VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that […]
Tomorrow Health Raises $60 Million Series B to Scale Quality Home-Based Care
Tomorrow Health, a home-based care company, closed a $60 million Series B round, bringing its […]
Evolved By Nature Raises $120M Series C, Led by Teachers' Venture Growth, to Scale Sustainable Activated Silk™ Technology for Global Impact
Evolved By Nature, the company creating a proprietary library of Activated Silk™ molecules from natural […]
Regard Raises $15.3 Million Series A to Accurately and Quickly Uncover Patient Diagnoses
Regard (formerly known as HealthTensor), a software company developing an artificial intelligence (AI) co-pilot for physicians […]
Centerline Biomedical Raises $33 Million in Series B Financing
Centerline Biomedical, Inc. (Centerline), a private medical technology company, announced the closing of a $33 million Series […]
Cordio Medical Raises $18 Million in Funding From Ceros and Peregrine Ventures to Accelerate Growth
Cordio Medical, a market-leading medical speech processing platform, announced its latest successful strategic investment round […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more